$2.83 Billion Worldwide Cord Blood Banking Services Industry to 2027 - Featuring Alphacord, Americord Registry, ATCC and California Cryobank Among Others

2022-10-24
PRNewswire
DUBLIN, Oct. 24, 2022 /PRNewswire/ -- The "Cord Blood Banking Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to
ResearchAndMarkets.com's offering.
The global cord blood banking services market reached a value of US$ 1.48 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 2.83 Billion by 2027, exhibiting a CAGR of 11.41% during 2021-2027.
Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Cord blood banking is a procedure of collecting and storing life-saving stem cells from the umbilical cord and placenta for future use. It uses hematopoietic stem cells that are present in the cord blood of the baby to develop it into red blood cells (RBCs), white blood cells (WBCs) and platelets.
It aids in the treatment of cancer, blood diseases and immune system disorders as cord blood banking is less complicated, painful and risky for the donor compared to the collection of stem cells from bone marrow. As a result, it finds extensive applications in hospitals, research institutes, and specialty clinics.
The growing prevalence of different cancers, such as lymphoma and leukemia, due to longer working hours, stressful lives, and excessive smoking and alcohol consumption represents one of the key factors driving the market. Moreover, there is an increase in the utilization of cord blood banking services for the treatment of immunodeficiency disorders across the globe.
This, coupled with the increasing awareness among individuals about the benefits and wide availability of cord blood banking service providers, is propelling the growth of the market. In addition, governments of several countries are extensively investing in research and development (R&D) activities to facilitate clinical trials of cord blood stem cells.
In line with this, the growing number of patients with damaged bone marrow worldwide is positively influencing the market. Besides this, the rising diagnostic screening of cord blood in private centers as per guidelines and regulations of regulatory authorities is offering lucrative growth opportunities to industry investors. Additionally, the expanding healthcare industry is strengthening the growth of the market.
Key Questions Answered in This Report:
How has the global cord blood banking services market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global cord blood banking services market?
What are the key regional markets?
What is the breakup of the market based on the component?
What is the breakup of the market based on the storage services?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global cord blood banking services market and who are the key players?
What is the degree of competition in the industry?
Key Topics Covered:
2 Scope and Methodology
3 Executive Summary
4.1 Overview
4.2 Key Industry Trends
5 Global Cord Blood Banking Services Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Component
6.1 Cord Blood
6.1.1 Market Trends
6.1.2 Market Forecast
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Storage Services
7.1 Public Cord Blood Banks
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Private Cord Blood Banks
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Application
8.1.1 Market Trends
8.1.2 Market Forecast
8.2.1 Market Trends
8.2.2 Market Forecast
8.3.1 Market Trends
8.3.2 Market Forecast
8.4.1 Market Trends
8.4.2 Market Forecast
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by Region
10 SWOT Analysis
11 Value Chain Analysis
12 Porters Five Forces Analysis
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 ATCC
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 California Cryobank
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Global Cord Blood Corporation
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 LifeBank
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 National Cord Blood Program
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
For more information about this report visit https://www.researchandmarkets.com/r/f2xhv
Media Contact:
Laura Wood | +353-1-481-1716 | [email protected]
Logo - https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
机构
适应症
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。